TrialPath
Recruiting

A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

NCT07185009 · Sanofi
In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

Official title
A Multicenter, Multinational, Randomized, Double-blind, Placebo-Controlled, Phase 3 Maintenance Study to Evaluate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
About this study
This is a multicenter, randomized, double-blind, placebo-controlled Phase 3 maintenance study to evaluate the efficacy and safety of duvakitug in participants with moderately to severely active Ulcerative Colitis (UC). Study details include: The study duration may be up to 286 weeks including: * 40-week Pivotal Maintenance Sub-Study * 240-week Open-Label Extension (OLE) Sub-Study * 45-day Follow-up Visit Note: For the participants who do not enroll into OLE Sub-Study, the duration will be up to 46 weeks, including the 40-week maintenance period and a 45-day follow-up visit. The treatment duration may be up to 280 weeks including: * 40 weeks in Pivotal Maintenance Sub-Study * 240 weeks in OLE Sub-Study The total number of on-site visit will be up to 32: * 21 visits in the Pivotal Maintenance Sub-Study. * 11 visits in the OLE Sub-Study.
Eligibility criteria
Inclusion Criteria: * Participants aged ≥18 and ≤80 years of age at Baseline. (Where locally permissible, participants 16 to \<18 years of age who meet the definition of Tanner stage 5 for development) * Pivotal Maintenance Sub-Study: Participants who achieved clinical response and completed endoscopy at the end of SUNSCAPE-1 * OLE Sub-Study: Participants who complete the Pivotal Maintenance Sub-Study or participation in the TV48574-IMM-20038 Study Exclusion Criteria: * Participants with medical or compliance conditions that are deemed unsuitable for the study by the investigator * Participants with a known hypersensitivity to duvakitug that makes the participant unsuitable for the study by the investigator The above information is not intended to contain all considerations relevant to a participant's potential participation in a clinical trial.
Study design
Enrollment target: 751 participants
Allocation: randomized
Masking: quadruple
Age groups: child, adult, older_adult
Timeline
Starts: 2026-01-16
Estimated completion: 2033-04-28
Last updated: 2026-10-16
Interventions
Drug: DuvakitugDrug: Placebo
Primary outcomes
  • • Pivotal Maintenance Sub-Study Cohort 1: Proportion of participants achieving clinical remission by modified Mayo Score (mMS). (Week 40)
Sponsor
Sanofi · industry
With: Teva Branded Pharmaceutical Products R&D LLC
Contacts & investigators
ContactTrial Transparency email recommended (Toll free for US & Canada) · contact · contact-us@sanofi.com · 800-633-1610
All locations (171)
Del Sol Research Management, LLC - Site Number: 8400012Recruiting
Tucson, Arizona, United States
Southern California GI & Liver Centers - Site Number: 8400062Recruiting
Coronado, California, United States
United Medical Doctors CA - Site Number: 8400044Recruiting
Murrieta, California, United States
Om Research, LLC - Victorville - Site Number: 8400022Recruiting
Victorville, California, United States
Peak Gastroenterology Associates - Colorado Springs - Site Number: 8400039Recruiting
Colorado Springs, Colorado, United States
Clinical Research of Osceola - Site Number: 8400013Recruiting
Kissimmee, Florida, United States
Bioresearch Partner-Kendale Lakes - Site Number: 8400053Recruiting
Miami, Florida, United States
NMC Research LLC - Site Number: 8400033Recruiting
Tampa, Florida, United States
Atlanta Gastroenterology Associates-Site Number: 8400109Recruiting
Atlanta, Georgia, United States
Grand Teton Research Group, PLLC-Site Number: 8400127Recruiting
Idaho Falls, Idaho, United States
GI Alliance - Gurnee-Site Number:Recruiting
Gurnee, Illinois, United States
Gastroenterology Health Partners, PLLC - New Albany - Site Number: 8400100Recruiting
New Albany, Indiana, United States
University of Kentucky Hospital/UK Albert B. Chandler Hospital-Site Number: 8400058Recruiting
Lexington, Kentucky, United States
GI Alliance - Baton Rouge - Site Number: 8400129Recruiting
Baton Rouge, Louisiana, United States
Texas Digestive Disease Consultants, PLLC d/b/a GI Alliance - Mandeville - Site Number: 8400128Recruiting
Mandeville, Louisiana, United States
Delta Research Partners - Site Number: 8400087Recruiting
Monroe, Louisiana, United States
UMass Memorial Medical Center-Site Number: 8400121Recruiting
Worcester, Massachusetts, United States
Gastroenterology Associates of Western Michigan - Site Number: 8400060Recruiting
Wyoming, Michigan, United States
Gateway Gastroenterology - Site Number: 8400097Recruiting
Chesterfield, Missouri, United States
BVL Clinical Research - Site Number: 8400005Recruiting
Liberty, Missouri, United States
Premier Health Research, LLC-Site Number: 8400114Recruiting
Sparta, New Jersey, United States
MedTraits NY - Site Number: 8400045Recruiting
Maspeth, New York, United States
NYU Langone Health-Site Number: 8400091Recruiting
New York, New York, United States
Weill Cornell Medicine - NewYork-Presbyterian Hospital - Site Number: 8400040Recruiting
New York, New York, United States
Lenox Hill Hospital-Site Number: 8400052Recruiting
New York, New York, United States
New York Gastroenterology Associates - Site Number: 8400009Recruiting
New York, New York, United States
Cross Creek Medical Clinic - Site Number: 8400057Recruiting
Fayetteville, North Carolina, United States
Ohio Gastroenterology Group Inc. - Site Number: 8400006Recruiting
Columbus, Ohio, United States
North Shore Gastroenterology Research - Site Number: 8400130Recruiting
Westlake, Ohio, United States
The Allegheny Health Network (AHN) Center for Digestive Health-Site Number: 8400107Recruiting
Pittsburgh, Pennsylvania, United States
University Gastroenterology-Site Number: 8400103Recruiting
Providence, Rhode Island, United States
One of a Kind Clinical Research Center TX, LLC-Site Number: 8400125Recruiting
Kingwood, Texas, United States
GI Alliance - Lubbock - Site Number: 8400092Recruiting
Lubbock, Texas, United States
Gastroenterology Research of San Antonio LLC - Site Number: 8400054Recruiting
San Antonio, Texas, United States
Texas Digestive Disease Consultants, PLLC. dba GI Alliance - Southlake - Corporate Office - Site Number: 8400101Recruiting
Southlake, Texas, United States
Tyler Research Institute, LLC - Site Number: 8400095Recruiting
Tyler, Texas, United States
The Vancouver Clinic Inc. P.S. - Site Number: 8400090Recruiting
Vancouver, Washington, United States
Investigational Site Number : 0320007Recruiting
Rosario, Santa Fe Province, Argentina
Investigational Site Number : 0360001Recruiting
South Brisbane, Australia
Investigational Site Number : 0400003Recruiting
Krems, Lower Austria, Austria
Investigational Site Number : 0400002Recruiting
Salzburg, Austria
Investigational Site Number : 0560003Recruiting
Yvoir, Belgium
Investigational Site Number : 1000003Recruiting
Gorna Oryahovitsa, Oblast Veliko Tirnovo, Bulgaria
Investigational Site Number : 1000001Recruiting
Sofia, Bulgaria
Investigational Site Number : 1240003Recruiting
Toronto, Ontario, Canada
Investigational Site Number : 1240004Recruiting
Edmonton, Canada
Investigational Site Number : 1240009Recruiting
Hamilton, Canada
Investigational Site Number : 1240013Recruiting
London, Canada
Investigational Site Number : 1240006Recruiting
New Westminster, Canada
Investigational Site Number : 1520004Recruiting
Santiago, Chile
Investigational Site Number : 1520002Recruiting
Santiago, Chile
Investigational Site Number : 1520001Recruiting
Viña del Mar, Chile
Investigational Site Number : 1560002Recruiting
Guangzhou, Guangdong, China
Investigational Site Number : 1560026Recruiting
Huizhou, Guangdong, China
Investigational Site Number : 1560018Recruiting
Wuxi, Jiangsu, China
Investigational Site Number : 1560001Recruiting
Chengdu, Sichuan, China
Investigational Site Number : 1560027Recruiting
Beijing, China
Investigational Site Number : 1560028Recruiting
Hefei, China
Investigational Site Number : 1560052Recruiting
Kunming, China
Investigational Site Number : 1560020Recruiting
Shanghai, China
Investigational Site Number : 2030011Recruiting
Hradec Králové, Czechia
Investigational Site Number : 2500009Recruiting
Amiens, France
Investigational Site Number : 2500008Recruiting
Besançon, France
Investigational Site Number : 2500003Recruiting
Créteil, France
Investigational Site Number : 2500004Recruiting
La Tronche, France
Investigational Site Number : 2500010Recruiting
Lille, France
Investigational Site Number : 2500012Recruiting
Marseille, France
Investigational Site Number : 2500007Recruiting
Nantes, France
Investigational Site Number : 2500013Recruiting
Nice, France
Investigational Site Number : 2500001Recruiting
Paris, France
Investigational Site Number : 2500002Recruiting
Saint-Priest-en-Jarez, France
Investigational Site Number : 2500011Recruiting
Toulouse, France
Investigational Site Number : 2500006Recruiting
Vandœuvre-lès-Nancy, France
Investigational Site Number : 2680007Recruiting
Kutaisi, Georgia
Investigational Site Number : 2680006Recruiting
Tbilisi, Georgia
Investigational Site Number : 2680008Recruiting
Tbilisi, Georgia
Investigational Site Number : 2680003Recruiting
Tbilisi, Georgia
Investigational Site Number : 2680002Recruiting
Tbilisi, Georgia
Investigational Site Number : 2680005Recruiting
Tbilisi, Georgia
Investigational Site Number : 2680009Recruiting
Tbilisi, Georgia
Investigational Site Number : 2760009Recruiting
Tübingen, Baden-Wurttemberg, Germany
Investigational Site Number : 2760005Recruiting
Ulm, Baden-Wurttemberg, Germany
Investigational Site Number : 2760015Recruiting
Leipzig, Saxony, Germany
Investigational Site Number : 2760011Recruiting
Halle, Saxony-Anhalt, Germany
Investigational Site Number : 2760001Recruiting
Kiel, Schleswig-Holstein, Germany
Investigational Site Number : 2760003Recruiting
Berlin, Germany
Investigational Site Number : 2760010Recruiting
Minden, Germany
Investigational Site Number : 3000002Recruiting
Athens, Greece
Investigational Site Number : 3480004Recruiting
Budapest, Hungary
Investigational Site Number : 3480002Recruiting
Budapest, Hungary
Investigational Site Number : 3480001Recruiting
Veszprém, Hungary
Investigational Site Number : 3760001Recruiting
Jerusalem, Israel
Investigational Site Number : 3760002Recruiting
Tel Aviv, Israel
Investigational Site Number : 3800009Recruiting
Rome, Italy
Investigational Site Number : 3800003Recruiting
Rozzano, Italy
Investigational Site Number : 3800005Recruiting
Turin, Italy
Investigational Site Number : 3920059Recruiting
Bunkyō City, Japan
Investigational Site Number : 3920039Recruiting
Chikushino-shi, Japan
Investigational Site Number : 3920031Recruiting
Hachiōji, Japan
Investigational Site Number : 3920049Recruiting
Kagoshima, Japan
Investigational Site Number : 3920030Recruiting
Kamakura, Japan
Investigational Site Number : 3920018Recruiting
Kashiwa, Japan
Investigational Site Number : 3920019Recruiting
Kobe, Japan
Investigational Site Number : 3920033Recruiting
Kōriyama, Japan
Investigational Site Number : 3920051Recruiting
Kumamoto, Japan
Investigational Site Number : 3920007Recruiting
Minato, Japan
Investigational Site Number : 3920041Recruiting
Nagaoka, Japan
Investigational Site Number : 3920013Recruiting
Nishinomiya, Japan
Investigational Site Number : 3920002Recruiting
Osaka, Japan
Investigational Site Number : 3920014Recruiting
Saga, Japan
Investigational Site Number : 3920029Recruiting
Sapporo, Japan
Investigational Site Number : 3920042Recruiting
Sapporo, Japan
Investigational Site Number : 3920003Recruiting
Sendai, Japan
Investigational Site Number : 3920055Recruiting
Takamatsu, Japan
Investigational Site Number : 3920057Recruiting
Takamatsu, Japan
Investigational Site Number : 3920032Recruiting
Toyama, Japan
Investigational Site Number : 3920015Recruiting
Toyohashi, Japan
Investigational Site Number : 3920009Recruiting
Tsu, Japan
Investigational Site Number : 3920035Recruiting
Yokohama, Japan
Investigational Site Number : 4400001Recruiting
Kaunas, Lithuania
Investigational Site Number : 4400002Recruiting
Panevezys, Lithuania
Investigational Site Number : 4980004Recruiting
Chisinau, Moldova
Investigational Site Number : 5280002Recruiting
Amsterdam, Netherlands
Investigational Site Number : 6160026Recruiting
Bydgoszcz, Poland
Investigational Site Number : 6160019Recruiting
Bydgoszcz, Poland
Investigational Site Number : 6160013Recruiting
Elblag, Poland
Investigational Site Number : 6160014Recruiting
Katowice, Poland
Investigational Site Number : 6160022Recruiting
Krakow, Poland
Investigational Site Number : 6160030Recruiting
Kłodzko, Poland
Investigational Site Number : 6160034Recruiting
Lublin, Poland
Investigational Site Number : 6160010Recruiting
Opole, Poland
Investigational Site Number : 6160018Recruiting
Poznan, Poland
Investigational Site Number : 6160025Recruiting
Rzeszów, Poland
Investigational Site Number : 6160004Recruiting
Sopot, Poland
Investigational Site Number : 6160007Recruiting
Staszów, Poland
Investigational Site Number : 6160002Recruiting
Szczecin, Poland
Investigational Site Number : 6160020Recruiting
Szczecin, Poland
Investigational Site Number : 6160023Recruiting
Torun, Poland
Investigational Site Number : 6160012Recruiting
Wadowice, Poland
Investigational Site Number : 6160005Recruiting
Warsaw, Poland
Investigational Site Number : 6160008Recruiting
Warsaw, Poland
Investigational Site Number : 6160006Recruiting
Wroclaw, Poland
Investigational Site Number : 6160028Recruiting
Wroclaw, Poland
Investigational Site Number : 6160017Recruiting
Wroclaw, Poland
Investigational Site Number : 6880001Recruiting
Belgrade, Serbia
Investigational Site Number : 6880002Recruiting
Belgrade, Serbia
Investigational Site Number : 6880007Recruiting
Belgrade, Serbia
Investigational Site Number : 7030003Recruiting
Košice, Slovakia
Investigational Site Number : 7030002Recruiting
Prešov, Slovakia
Investigational Site Number : 7030004Recruiting
Prešov, Slovakia
Investigational Site Number : 7100002Recruiting
Cape Town, South Africa
Investigational Site Number : 7100005Recruiting
Claremont, South Africa
Investigational Site Number : 7100004Recruiting
Durban, South Africa
Investigational Site Number : 4100010Recruiting
Ansan-si, South Korea
Investigational Site Number : 4100008Recruiting
Busan, South Korea
Investigational Site Number : 4100004Recruiting
Daegu, South Korea
Investigational Site Number : 4100006Recruiting
Seoul, South Korea
Investigational Site Number : 4100005Recruiting
Suwon, South Korea
Investigational Site Number : 7240002Recruiting
Huelva, Spain
Investigational Site Number : 7560001Recruiting
Bern, Switzerland
Investigational Site Number : 1580001Recruiting
Taoyuan City, Taiwan
Investigational Site Number : 8040003Recruiting
Chernivtsi, Ukraine
Investigational Site Number : 8040001Recruiting
Kyiv, Ukraine
Investigational Site Number : 8040002Recruiting
Kyiv, Ukraine
Investigational Site Number : 8040004Recruiting
Lviv, Ukraine
Investigational Site Number : 8040005Recruiting
Lviv, Ukraine
Investigational Site Number : 8040006Recruiting
Uzhhorod, Ukraine
Investigational Site Number : 8040010Recruiting
Vinnytsia, Ukraine
Investigational Site Number : 8040009Recruiting
Vinnytsia, Ukraine
Investigational Site Number : 8040008Recruiting
Vinnytsia, Ukraine
Investigational Site Number : 8260001Recruiting
London, United Kingdom
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis · TrialPath